AGBL2 (AGBL carboxypeptidase 2)

2011-05-01  

Identity

HGNC
LOCATION
11p11.2
LOCUSID
ALIAS
CCP2
FUSION GENES

Other Information

Locus ID:

NCBI: 79841
MIM: 617345
HGNC: 26296
Ensembl: ENSG00000165923

Variants:

dbSNP: 79841
ClinVar: 79841
TCGA: ENSG00000165923
COSMIC: AGBL2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000165923ENST00000357610H9KV53
ENSG00000165923ENST00000525123Q5U5Z8
ENSG00000165923ENST00000525123A0A140VKH9
ENSG00000165923ENST00000528244F6U0I4
ENSG00000165923ENST00000528609J9JIH1
ENSG00000165923ENST00000528632E9PS54
ENSG00000165923ENST00000529154E9PI49
ENSG00000165923ENST00000530577E9PRJ1
ENSG00000165923ENST00000530969E9PJH3
ENSG00000165923ENST00000532595E9PR59

Expression (GTEx)

0
5
10
15
20
25
30
35
40
45

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
213039782011Tumor suppressor RARRES1 interacts with cytoplasmic carboxypeptidase AGBL2 to regulate the α-tubulin tyrosination cycle.31
291269122018AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma.8
248845162014Clinical implications of AGBL2 expression and its inhibitor latexin in breast cancer.6
259160892015Effects of AGBL2 on cell proliferation and chemotherapy resistance of gastric cancer.1

Citation

Dessen P

AGBL2 (AGBL carboxypeptidase 2)

Atlas Genet Cytogenet Oncol Haematol. 2011-05-01

Online version: http://atlasgeneticsoncology.org/gene/52204/agbl2